SUMO modification and DNA damage response in cancer therapy
癌症治疗中的 SUMO 修饰和 DNA 损伤反应
基本信息
- 批准号:8068284
- 负责人:
- 金额:$ 41.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvanced Malignant NeoplasmAffinityAmino Acid SequenceBindingBiochemicalBiologicalCell DeathCellsConsensusDNA DamageDNA Double Strand BreakDNA FingerprintingDNA RepairDevelopmentDouble Strand Break RepairEventFutureGenomic InstabilityGoalsHealthKnowledgeLaboratoriesLeadMalignant NeoplasmsMediatingMethodsModificationMolecularPathway interactionsPeptide LibraryPeptidesPharmaceutical PreparationsPlayPost-Translational Protein ProcessingProcessProtein FamilyProtein IsoformsProteinsRadiationReagentResearchResistanceRoleSignal PathwaySolutionsTherapeuticTranslational ResearchUbiquitinbasecancer cellcancer therapychemotherapyclinical applicationcombinatorialdesignimprovedin vivoinhibitor/antagonistinnovationkillingsneoplastic cellnovelpeptidomimeticsprotein protein interactionreceptorrepairedresponse
项目摘要
DESCRIPTION (provided by applicant): Post-translational modifications by the Small Ubiquitin-like Modifier (SUMO) family of proteins have been established as critical events in the cellular response to a wide range of DNA damaging reagents and radiation. Both radiation and chemotherapy kill cancer cells by inducing DNA damage that leads to genomic instability and/or cell death. Therefore, DNA repair mechanisms, which are SUMOylation dependent, play a critical role in the resistance of cancer cells to these treatments. However, the mechanism of SUMOylation in DNA damage response is poorly understood. We hypothesize that SUMO isoform-specific receptor proteins mediate SUMO isoform-specific functions in the repair of DNA damage. The proposed studies are based on our Preliminary Studies, which show that inhibition of SUMO-dependent protein-protein interactions inhibited the repair of DNA double-strand breaks, and increased the sensitivity of tumor cells to radiation and chemotherapeutic drugs that induce DNA damage. The proposed research integrates several scientifically diverse but highly synergistic approaches, including structural and molecular biological methods, to investigate the role of SUMOylation in the repair of DNA double-strand breaks, and to elucidate the functions of different SUMO isoforms in these processes. These studies will also investigate the structural basis for SUMO isoform-specific recognition, which will provide information for designing inhibitors of SUMO isoform-specific functions. The proposed studies address an innovative concept, and could lead to the establishment of a new paradigm of targeting SUMO-dependent mechanisms for cancer therapy. PUBLIC HEALTH REVELANCE: The overall goal of this proposal is to investigate the role of SUMOylation in DNA damage response.
描述(由申请人提供):小泛素样修饰物(Small Ubiquitin-like Modifier, SUMO)蛋白家族的翻译后修饰已被确定为细胞对各种DNA损伤试剂和辐射反应的关键事件。放疗和化疗都是通过诱导DNA损伤来杀死癌细胞,从而导致基因组不稳定和/或细胞死亡。因此,依赖于SUMOylation的DNA修复机制在癌细胞对这些治疗的抗性中起着关键作用。然而,SUMOylation在DNA损伤反应中的作用机制尚不清楚。我们假设SUMO亚型特异性受体蛋白在DNA损伤修复中介导SUMO亚型特异性功能。我们的初步研究表明,抑制sumo依赖的蛋白-蛋白相互作用抑制DNA双链断裂的修复,并增加肿瘤细胞对诱导DNA损伤的放射和化疗药物的敏感性。该研究整合了几种科学上不同但高度协同的方法,包括结构和分子生物学方法,以研究SUMO化在DNA双链断裂修复中的作用,并阐明不同的SUMO异构体在这些过程中的功能。这些研究还将探讨SUMO异构体特异性识别的结构基础,这将为设计SUMO异构体特异性功能抑制剂提供信息。提出的研究解决了一个创新的概念,并可能导致建立针对sumo依赖机制的癌症治疗的新范式。公共卫生相关性:本提案的总体目标是研究SUMOylation在DNA损伤反应中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yuan Chen其他文献
Yuan Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yuan Chen', 18)}}的其他基金
Surgical Oncologists as Scientists (SOAS) Training Program
肿瘤外科医师科学家 (SOAS) 培训计划
- 批准号:
10555596 - 财政年份:2023
- 资助金额:
$ 41.08万 - 项目类别:
K-Ras sumoylation in cell proliferation and transformation
细胞增殖和转化中的 K-Ras 修饰
- 批准号:
9402787 - 财政年份:2017
- 资助金额:
$ 41.08万 - 项目类别:
K-Ras sumoylation in cell proliferation and transformation
细胞增殖和转化中的 K-Ras 修饰
- 批准号:
9924462 - 财政年份:2017
- 资助金额:
$ 41.08万 - 项目类别:
Targeting c-Myc and Proteasome Inhibitor Resistance in Multiple Myeloma
靶向多发性骨髓瘤中的 c-Myc 和蛋白酶体抑制剂耐药性
- 批准号:
9942394 - 财政年份:2017
- 资助金额:
$ 41.08万 - 项目类别:
SENP:Conformational Dynamics and Inhibition by Small Molecules
SENP:构象动力学和小分子的抑制
- 批准号:
8287411 - 财政年份:2012
- 资助金额:
$ 41.08万 - 项目类别:
SENP:Conformational Dynamics and Inhibition by Small Molecules
SENP:构象动力学和小分子的抑制
- 批准号:
8454447 - 财政年份:2012
- 资助金额:
$ 41.08万 - 项目类别:
SENP:Conformational Dynamics and Inhibition by Small Molecules
SENP:构象动力学和小分子的抑制
- 批准号:
8649059 - 财政年份:2012
- 资助金额:
$ 41.08万 - 项目类别:
SENP:Conformational Dynamics and Inhibition by Small Molecules
SENP:构象动力学和小分子的抑制
- 批准号:
8829872 - 财政年份:2012
- 资助金额:
$ 41.08万 - 项目类别:














{{item.name}}会员




